Chemotherapeutic palliative approaches in the treatment of lymphoma

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

A number of diverse therapies can be used to treat relapsed non-Hodgkin's lymphoma, with the most common treatment modality being conventional salvage chemotherapy using agents different from those used initially. Alternative therapies that may be palliative in certain clinical situations include localized radiation therapy, novel chemotherapeutic agents (like chlorodeoxyadenosine, fludarabine, or idarubicin), or conjugated monoclonal antibody therapy. The use of high-dose chemotherapy and bone marrow or hematopoietic stem cell transplantation can be a successful treatment option for patients with relapsed lymphoma; however, this should be considered as a therapy of curative intent and not only for palliative therapy.

Original languageEnglish (US)
Pages (from-to)53-57
Number of pages5
JournalSeminars in Oncology
Volume22
Issue numberSUPPL. 3
StatePublished - 1995

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Chemotherapeutic palliative approaches in the treatment of lymphoma'. Together they form a unique fingerprint.

Cite this